about
TMC207: the first compound of a new class of potent anti-tuberculosis drugsClinical Features and Treatment Outcomes of Patients with Drug-Resistant and Drug-Sensitive Tuberculosis: A Historical Cohort Study in Porto Alegre, BrazilSequence analysis of NAT2 gene in Brazilians: identification of undescribed single nucleotide polymorphisms and molecular modeling of the N-acetyltransferase 2 protein structure.The presence of a booster phenomenon among contacts of active pulmonary tuberculosis cases: a retrospective cohortPCR colorimetric dot-blot assay and clinical pretest probability for diagnosis of Pulmonary Tuberculosis in smear-negative patientsCost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosisCost effectiveness of antituberculosis interventions.Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus GenotypeÂŪMTBDRplus.Inflammatory and immunogenetic markers in correlation with pulmonary tuberculosis.Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil.Association between serum selenium level and conversion of bacteriological tests during antituberculosis treatment.Field evaluation of a rapid immunochromatographic test for tuberculosisOutcomes of TB treatment by HIV status in national recording systems in Brazil, 2003-2008.Anemia in hospitalized patients with pulmonary tuberculosis.Classification and regression tree (CART) model to predict pulmonary tuberculosis in hospitalized patients.Transmission of Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis patients.The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10.Liquid vs Solid Culture Medium to Evaluate Proportion and Time to Change in Management of Suspects of Tuberculosis-A Pragmatic Randomized Trial in Secondary and Tertiary Health Care Units in Brazil.Abandonment of Treatment for Latent Tuberculosis Infection and Socioeconomic Factors in Children and Adolescents: Rio De Janeiro, Brazil.Latent Tuberculosis Infection Diagnostic and Treatment Cascade among Contacts in Primary Health Care in a City of Sao Paulo State, Brazil: Cross-Sectional StudyAssociations between systemic inflammation, mycobacterial loads in sputum and radiological improvement after treatment initiation in pulmonary TB patients from Brazil: a prospective cohort study.Tuberculosis incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.Catastrophic care-seeking costs as an indicator for lung health.Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 miceSustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation.RDRio Mycobacterium tuberculosis infection is associated with a higher frequency of cavitary pulmonary disease.Safety and effectiveness of HAART in tuberculosis-HIV co-infected patients in BrazilTuberculosis caused by RDRio Mycobacterium tuberculosis is not associated with differential clinical featuresAdministrative measures for preventing Mycobacterium tuberculosis infection among healthcare workers in a teaching hospital in Rio de Janeiro, BrazilTranscriptomic Biomarkers for Tuberculosis: Evaluation of DOCK9. EPHA4, and NPC2 mRNA Expression in Peripheral Blood.Prevalence of latent Mycobacterium tuberculosis infection in prisoners.Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis.Usefulness of the polymerase chain reaction dot-blot assay, used with Ziehl-Neelsen staining, for the rapid and convenient diagnosis of pulmonary tuberculosis in human immunodeficiency virus-seropositive and -seronegative individuals.Performance of a molecular assay to detect Mycobacterium tuberculosis complex DNA in clinical specimens: multicenter study in Brazil.Evaluation of the Mean Cost and Activity Based Cost in the Diagnosis of Pulmonary Tuberculosis in the Laboratory Routine of a High-Complexity Hospital in Brazil.Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action.Epidemiological aspects of tuberculosis in children and adolescents in Rio de Janeiro.Outcomes from patients with presumed drug resistant tuberculosis in five reference centers in Brazil.A comparison of tuberculosis diagnostic systems in a retrospective cohort of HIV-infected children in Rio de Janeiro, Brazil.Development of multiplex assay for rapid characterization of Mycobacterium tuberculosis.
P50
Q24632091-DD59DFEF-9B57-4594-8D88-7EF09D56E140Q28553427-836F4E4C-2135-4669-98DD-FC59EBE6E71BQ30382475-2C5EB097-B1E2-42B6-A0F4-225536FFDB15Q33279360-4C7079E2-DA27-438F-8AF7-3A9F96FE06CBQ33311619-DC691816-4045-42E6-A6B2-AB91800BD93FQ33521520-D5CF532F-7F5A-4DE9-9178-0CA6E019CD27Q33571810-A012E042-AF66-4694-9A31-2C01306AE6F5Q33732298-6B1FC733-42C7-49E8-8CB4-FDFBE939374EQ33824263-917D2952-C35A-4F0C-A5F1-CB14DF8C1022Q33852410-4679F62A-CE6C-486F-A110-9276432C874CQ33942919-5BE4401F-FDE0-4D6E-B390-AC0050740B64Q34196207-B50A3F4B-8D03-4F1C-8D9A-2E658AF9A0DBQ34211754-DAD00614-24E8-47B5-87F5-3FED87430DDEQ34360236-62C309D3-0E97-4BE1-AB80-1869BF32BD21Q34370162-F1D1A3B3-DF54-46A6-AA78-B5FBB5559072Q34467350-806AF232-FE04-4E01-9021-E8D429E1DE34Q34942368-9583F6BF-865D-41E5-B6E8-BCECF0F1FA0AQ35653817-20AAE657-8B13-449E-8377-882452F59215Q36009699-DC7ECF09-1E45-4E3F-AE9E-88E6FD827F28Q36048298-59626874-0732-4552-A28C-6D446F8EA97DQ36096192-3446F2D5-8AB5-4814-BA8B-165919B26211Q36137104-AAE3FDE2-FAF5-4647-A391-CB17CBB17754Q36303968-AA190C15-0628-43DE-85B3-4D01BB7F7056Q36312141-0140DC86-E836-4EDB-B788-2745F9FC662FQ36338646-C98EC74E-6009-49D2-B501-7DFA72D67C50Q36747686-52FC2FD9-35A8-4D99-A368-1644EDB1E94CQ37020339-EFEFDBD1-9700-4A0B-9FAC-D931784E17F6Q37059870-A6144168-12BB-443C-ACE7-E067935FB000Q37332211-6691C39F-53C2-4981-A5FB-0BAD72809BE3Q37363016-1C148DD3-B8B5-4282-BF51-D42508EF84D7Q37392348-B21AF50E-8338-48AD-8066-227F8BFA8C9FQ37427183-53963362-E751-414C-85FD-E63C4C2EA8C5Q37481873-9D45315D-857B-4A50-B58D-1EBC214DB6C8Q37626263-C82F72FE-FABC-4D13-BAB7-5A3F1CF12622Q37642031-5BE60BAE-AE27-4A2E-9962-5E4E3DEAF3F8Q37757664-E4B5CD47-671C-433A-832F-5664D7F98554Q38036921-0B320D58-14AE-40F1-A0C6-2E093A0E87E5Q38623426-7524754A-3DE4-4AF9-BD04-D2C3418E5758Q38813731-22CD17A4-A5D1-429D-B642-0A9B009A94EBQ38905387-C6EDA926-12FF-41C3-9E9A-BC0B05AA724B
P50
description
onderzoeker
@nl
researcher
@en
Õ°ÕĨÕŋÕĄÕĶÕļÕŋÕļÕē
@hy
name
Afranio L Kritski
@ast
Afranio L Kritski
@en
Afranio L Kritski
@es
Afranio L Kritski
@nl
Afranio L Kritski
@sl
type
label
Afranio L Kritski
@ast
Afranio L Kritski
@en
Afranio L Kritski
@es
Afranio L Kritski
@nl
Afranio L Kritski
@sl
prefLabel
Afranio L Kritski
@ast
Afranio L Kritski
@en
Afranio L Kritski
@es
Afranio L Kritski
@nl
Afranio L Kritski
@sl
P106
P1153
7004055825
P31
P496
0000-0002-5900-6007